Literature DB >> 27903529

Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis.

Philipp-Sebastian Koch1, Victor Olsavszky1, Friederike Ulbrich1, Carsten Sticht2, Alexandra Demory1, Thomas Leibing1, Thomas Henzler3, Mathias Meyer3, Johanna Zierow1, Sven Schneider4, Katja Breitkopf-Heinlein5, Haristi Gaitantzi5, Bradley Spencer-Dene6, Bernd Arnold7, Kay Klapproth8, Kai Schledzewski1, Sergij Goerdt1, Cyrill Géraud1.   

Abstract

Microvascular endothelial cells (ECs) display a high degree of phenotypic and functional heterogeneity among different organs. Organ-specific ECs control their tissue microenvironment by angiocrine factors in health and disease. Liver sinusoidal endothelial cells (LSECs) are uniquely differentiated to fulfill important organ-specific functions in development, under homeostatic conditions, and in regeneration and liver pathology. Recently, Bmp2 has been identified by us as an organ-specific angiokine derived from LSECs. To study angiocrine Bmp2 signaling in the liver, we conditionally deleted Bmp2 in LSECs using EC subtype-specific Stab2-Cre mice. Genetic inactivation of hepatic angiocrine Bmp2 signaling in Stab2-Cre;Bmp2fl/fl (Bmp2LSECKO) mice caused massive iron overload in the liver and increased serum iron levels and iron deposition in several organs similar to classic hereditary hemochromatosis. Iron overload was mediated by decreased hepatic expression of hepcidin, a key regulator of iron homeostasis. Thus, angiocrine Bmp2 signaling within the hepatic vascular niche represents a constitutive pathway indispensable for iron homeostasis in vivo that is nonredundant with Bmp6. Notably, we demonstrate that organ-specific angiocrine signaling is essential not only for the homeostasis of the respective organ but also for the homeostasis of the whole organism.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27903529      PMCID: PMC5291964          DOI: 10.1182/blood-2016-07-729822

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

Review 1.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

2.  Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype.

Authors:  Anna Csiszar; Mansoor Ahmad; Kira E Smith; Nazar Labinskyy; Qun Gao; Gabor Kaley; John G Edwards; Michael S Wolin; Zoltan Ungvari
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis.

Authors:  Hidenori Matsubara; Daniel E Hogan; Elise F Morgan; Douglas P Mortlock; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2012-02-25       Impact factor: 4.398

4.  Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice.

Authors:  Andrea U Steinbicker; Thomas B Bartnikas; Lisa K Lohmeyer; Patricio Leyton; Claire Mayeur; Sonya M Kao; Alexandra E Pappas; Randall T Peterson; Donald B Bloch; Paul B Yu; Mark D Fleming; Kenneth D Bloch
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

5.  Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration.

Authors:  Daniel J Nolan; Michael Ginsberg; Edo Israely; Brisa Palikuqi; Michael G Poulos; Daylon James; Bi-Sen Ding; William Schachterle; Ying Liu; Zev Rosenwaks; Jason M Butler; Jenny Xiang; Arash Rafii; Koji Shido; Sina Y Rabbany; Olivier Elemento; Shahin Rafii
Journal:  Dev Cell       Date:  2013-07-18       Impact factor: 12.270

6.  Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.

Authors:  Chloé Latour; Céline Besson-Fournier; Delphine Meynard; Laura Silvestri; Ophélie Gourbeyre; Patricia Aguilar-Martinez; Paul J Schmidt; Mark D Fleming; Marie-Paule Roth; Hélène Coppin
Journal:  Hepatology       Date:  2015-11-12       Impact factor: 17.425

7.  Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation.

Authors:  Huiyong Chen; Tenzin Choesang; Huihui Li; Shuming Sun; Petra Pham; Weili Bao; Maria Feola; Mark Westerman; Guiyuan Li; Antonia Follenzi; Lionel Blanc; Stefano Rivella; Robert E Fleming; Yelena Z Ginzburg
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

8.  BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism.

Authors:  Claire Mayeur; Patricio A Leyton; Starsha A Kolodziej; Binglan Yu; Kenneth D Bloch
Journal:  Blood       Date:  2014-07-29       Impact factor: 22.113

9.  Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage.

Authors:  Carolin Mogler; Matthias Wieland; Courtney König; Junhao Hu; Anja Runge; Claudia Korn; Eva Besemfelder; Katja Breitkopf-Heinlein; Dorde Komljenovic; Steven Dooley; Peter Schirmacher; Thomas Longerich; Hellmut G Augustin
Journal:  EMBO Mol Med       Date:  2015-03       Impact factor: 12.137

10.  Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.

Authors:  Bi-Sen Ding; Zhongwei Cao; Raphael Lis; Daniel J Nolan; Peipei Guo; Michael Simons; Mark E Penfold; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  50 in total

Review 1.  Iron homeostasis: An anthropocentric perspective.

Authors:  Richard Coffey; Tomas Ganz
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 2.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

Review 3.  Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.

Authors:  Stefano Rivella
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

4.  To induce or not to induce: the fight over hepcidin regulation.

Authors:  Veena Sangkhae; Elizabeta Nemeth
Journal:  Haematologica       Date:  2019-06       Impact factor: 9.941

5.  Endothelial Bone Morphogenetic Protein 2 (Bmp2) Knockout Exacerbates Hemochromatosis in Homeostatic Iron Regulator (Hfe) Knockout Mice but not Bmp6 Knockout Mice.

Authors:  Xia Xiao; Som Dev; Susanna Canali; Abraham Bayer; Yang Xu; Aneesh Agarwal; Chia-Yu Wang; Jodie L Babitt
Journal:  Hepatology       Date:  2020-05-22       Impact factor: 17.425

6.  Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice.

Authors:  Chia-Yu Wang; Xia Xiao; Abraham Bayer; Yang Xu; Som Dev; Susanna Canali; Anil V Nair; Ricard Masia; Jodie L Babitt
Journal:  Hepatology       Date:  2019-08-13       Impact factor: 17.425

7.  Hepatic Smad7 overexpression causes severe iron overload in mice.

Authors:  Dilay Lai; Feng Teng; Seddik Hammad; Julia Werle; Thorsten Maas; Andreas Teufel; Martina U Muckenthaler; Steven Dooley; Maja Vujić Spasić
Journal:  Blood       Date:  2017-12-13       Impact factor: 22.113

8.  LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA.

Authors:  Audrey Belot; Ophélie Gourbeyre; Alexis Fay; Anais Palin; Céline Besson-Fournier; Chloé Latour; Corey R Hopkins; George F Tidmarsh; Hélène Coppin; Marie-Paule Roth; Matthew R Ritter; Charles C Hong; Delphine Meynard
Journal:  Haematologica       Date:  2019-12-05       Impact factor: 9.941

9.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

10.  Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.

Authors:  Chia-Yu Wang; Amanda B Core; Susanna Canali; Kimberly B Zumbrennen-Bullough; Sinan Ozer; Lieve Umans; An Zwijsen; Jodie L Babitt
Journal:  Blood       Date:  2017-04-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.